A systematic review of minor phytocannabinoids with promising neuroprotective potential. · PMID 32608035

Stone NL, Murphy AJ, England TJ, O'Sullivan SE.

Study design: Systematic review
Population / model: Human
Published: 2020-09-01
Journal: British journal of pharmacology

From the author abstract

“Further studies with these phytocannabinoids, and their combinations, are warranted across a range of neurodegenerative disorders.”

A short attributed excerpt. Read the full abstract and original paper for methods, results and limitations.

Read on PubMed ↗Full text in PMC ↗Publisher / DOI ↗

Keep in your notebook →

Figures from the paper

FIGURE 1: Overview of methodology used in the search process, identification, screening, eligibility, and inclusion — **FIGURE 1** Overview of methodology used in the search process, identification, screening, eligibility, and inclusionStone NL, Murphy AJ, England TJ, O'Sullivan SE. British journal of pharmacology (2020). Original figure · CC BY · Resized for display.

FIGURE 2: Structured and pharmacological profiles of some of the minor phytocannabinoids with cannabidiol (CBD) and tetrahydrocannabidiol (∆9‐THC) included for reference: — **FIGURE 2** Structured and pharmacological profiles of some of the minor phytocannabinoids with cannabidiol (CBD) and tetrahydrocannabidiol (∆9‐THC) included for reference: ∆9‐tetrahydrocannabinolic acid (∆9‐THCA), ∆9‐tetrahydrocannabinolic (∆9‐THCV), cannabidivarin (CBDV), cannabidiolic acid (CBDA), cannabichromene (CBC), cannabigerol (CBG), and cannabinol (CBN)Stone NL, Murphy AJ, England TJ, O'Sullivan SE. British journal of pharmacology (2020). Original figure · CC BY · Resized for display.

Citation and indexing details

PMID 32608035 · PMC7484504

Publication types: Journal Article; Systematic Review

Topic tags: Neurology

Metadata checked 2026-11-04. Study design and model tags follow indexing and explicit abstract terms. Citation counts are not evidence of benefit. An available full text does not by itself permit image reuse.